FN2 Earnings Intelligence
UnitedHealth Group Incorporated income statement (quarterly)
UnitedHealth Group Incorporated (UNH) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $30,717 | $28,596 | $27,210 | $28,001 | $28,585 | - | - |
| + Debt | $81,271 | $79,193 | $80,136 | $77,917 | $73,328 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $109,575 | $111,616 | $113,161 | $111,721 | $112,032 | $111,311.2 | $111,057.6 |
| % Growth | - | - | - | - | - | -1.6% | - |
| Gross Profit | $97,185 | $98,597 | $100,595 | $98,898 | $98,657 | - | - |
| % Margin | 88.7% | 88.3% | 88.9% | 88.5% | 88.1% | - | - |
| EBITDA | $10,180 | $6,234 | $5,414 | $10,019 | $9,031 | - | - |
| % Margin | 9.3% | 5.6% | 4.8% | 9.0% | 8.1% | - | - |
| Net Income | $6,292 | $3,406 | $2,348 | $6,280 | $5,484 | - | - |
| % Margin | 5.7% | 3.1% | 2.1% | 5.6% | 4.9% | - | - |
| Diluted EPS | $6.85 | $3.74 | $2.59 | $6.90 | $6.04 | $4.09 | $2.16 |
| % Growth | - | - | - | - | - | 58.1% | - |
| Operating Cash Flow | $5,456 | - | - | $8,912 | - | - | - |
| CapEx | $898 | - | - | $763 | - | - | - |
| Free Cash Flow | $4,558 | - | - | $8,149 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $109,575 | $111,616 | $113,161 | $111,721 | $112,032 | $111,311.2 | $111,057.6 |
| Gross Profit | $97,185 | $98,597 | $100,595 | $98,898 | $98,657 | - | - |
| EBITDA | $10,180 | $6,234 | $5,414 | $10,019 | $9,031 | - | - |
| Net Income | $6,292 | $3,406 | $2,348 | $6,280 | $5,484 | - | - |
| Diluted EPS | $6.85 | $3.74 | $2.59 | $6.90 | $6.04 | $4.09 | $2.16 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $30,717 | $28,596 | $27,210 | $28,001 | $28,585 |
| Short-term Debt | $9,986 | $5,698 | $7,737 | $6,477 | $3,827 |
| Long-term Debt | $71,285 | $73,495 | $72,399 | $71,440 | $69,501 |
| Total Debt | $81,271 | $79,193 | $80,136 | $77,917 | $73,328 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5,456 | - | - | $8,912 | - |
| Capital Expenditure | $898 | - | - | $763 | - |
| Free Cash Flow | $4,558 | - | - | $8,149 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 88.7% | 88.3% | 88.9% | 88.5% | 88.1% |
| EBITDA Margin | 9.3% | 5.6% | 4.8% | 9.0% | 8.1% |
| Net Margin | 5.7% | 3.1% | 2.1% | 5.6% | 4.9% |
| FCF Margin | 4.2% | - | - | 7.3% | - |
| Diluted EPS Growth | - | - | - | - | - |